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Abstract
Background: Although respiratory distress syndrome (RDS) is considered a disease of prematurity, there is evidence
to suggest heterogeneity between early and late gestation RDS. We examined the epidemiologic features of RDS
occurring at early and late gestation.
Methods: We conducted a retrospective cohort study including live births in the United States in 2005–06, with
information obtained from the National Center for Health Statistics. Early (<32 weeks) and late gestation RDS
(≥39 weeks) were contrasted in terms of risk factors and associations with pregnancy complications, obstetric
intervention and co-morbidity. Logistic regression was used to quantify the effects of risk factors, while other
associations were quantified descriptively.
Results: There were 27,971 RDS cases, yielding an incidence of 6.4 per 1000 live births. Early and late gestation RDS
differed in terms of risk factors, with factors such as multi-fetal gestation more strongly associated with early
(adjusted odds ratio [aOR] 11.6, 95 % confidence interval 11.0–12.2) compared with late gestation RDS (aOR 3.66,
95 % confidence interval 2.68–4.98). The morbidity correlates of early and late gestation RDS also differed
substantially; neonatal seizures were less strongly associated with early (OR 5.90, 95 % confidence interval 3.67–9.47)
compared with late gestation RDS (OR 33.1, 95 % confidence interval 27.2–40.2), while meconium aspiration
syndrome was not significantly associated with early gestation RDS (OR 1.87, 95 % confidence interval 0.94–3.72)
and very strongly associated with late gestation RDS (OR 39.8, 95 % confidence interval 34.7–45.6).
Conclusions: Differences in risk factors and morbidity correlates of early and late gestation RDS suggest that these
entities represent two distinct diseases.
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Background
Respiratory distress syndrome in the newborn (RDS) is a
disease caused by the absence or inadequate production of
pulmonary surfactant and the related underdevelopment of
the lungs [1, 2]. The gestational age-specific incidence of
RDS has a bimodal distribution, with a first peak in
incidence rates at early gestation and a second peak at late
term gestation [3]. Such a bimodal pattern of disease
incidence has been traditionally interpreted as suggesting
disease heterogeneity. For instance, the bimodal age
incidence curve of Hodgkin disease was first described by
MacMahon in the 1950s and ascribed to etiologic hetero-
geneity [4, 5]. Subsequent discoveries, including the detec-
tion of Epstein-Barr virus (EBV) DNA in tumour cells,
have led to the understanding that the early incidence of
Hodgkin disease among young adults is caused by primary
infection (non-EBV), while the second peak among older
adults is due to loss of immunity to latent infection (mostly
EBV) [6, 7]. Similarly, the bimodal gestational age incidence
of RDS suggests that RDS occurring at early and late gesta-
tion represents two distinct disease entities [3]. Proposed
mechanisms for RDS at term include meconium aspiration
syndrome [8], diabetes [9], cesarean delivery, in particular
cesarean delivery without labour [10–13], delay in onset of
respiration [14], birth asphyxia (neonatal encephalopathy)
[14], congenital anomalies [8], and rare genetic mutations
of surfactant protein [2].
Newborns with RDS at late term gestation comprise a
significant and under-recognized subpopulation of RDS
infants [15]. In addition, studies have not adequately
characterized RDS at late term, even though the condition
was documented in 1959 and has been routinely identified
in subsequent years [8, 14, 15]. We hypothesized that the
peak in the incidence of RDS at late gestation signifies
etiologic and other heterogeneity as compared with early
gestation RDS. We therefore carried out a study to describe
the risk factors, morbidity correlates and other epidemio-
logic features of RDS occurring at early and late gestation.
Methods
The study was a retrospective cohort study of live births
in the United States in 2005 and 2006. These years were
chosen for the study as they represented the most recent
period that information on RDS status was collected on
the birth certificate. Information on these infants was
obtained from the National Center for Health Statistics
birth-infant death (period linked) data files, a set of publi-
cally available databases maintained by the US Center for
Disease Control [16]. These files included routinely
collected demographic information, maternal and infant
characteristics, and birth outcomes. Data were uniformly
coded according to standard specifications and were
edited and reviewed to satisfy quality control standards
[16]. We restricted our study to live births for whom
information was based on the 1989 revision of the US
standard certificate of live birth, as this version included
information on whether the infant was diagnosed with
RDS. RDS was defined as a diagnosis of hyaline
membrane disease recorded in the birth certificate.
Further, we excluded live births with a gestational age
outside the 24 to 43 weeks range. Gestational age at birth
was based on the clinical estimate of gestation, which
studies demonstrate to be more accurate than gestational
age based on the reported last menstrual period [17, 18].
We first determined the incidence pattern of RDS by
gestational age using the fetuses-at-risk approach [3].
For these calculations, gestational age-specific incidence
rates were estimated by using number of RDS cases at
any gestational week in the numerator and the number
of fetuses (at risk of birth and RDS) at that gestation in
the denominator. Cases of RDS were also categorized
into those that occurred at <32 weeks, 32–36 weeks,
37–38 weeks and ≥39 weeks, with the gestational age
categories chosen a priori based on the previously
described incidence pattern of RDS [3]. The rate of RDS
at <32 weeks (cumulative incidence between 24 and
31 weeks) was calculated by dividing the number of RDS
cases <32 weeks by the number of fetuses at 24 weeks,
while the rate of RDS at ≥39 weeks (cumulative inci-
dence between 39 and 43 weeks) was calculated by
dividing the number of RDS cases ≥39 weeks by the
number of fetuses at 39 weeks. The primary analysis
contrasting early vs late gestation RDS in terms of risk
factors and morbidity focused on early gestation RDS (at
<32 weeks) and late gestation RDS (at ≥39 weeks).
The fetuses-at-risk approach was used for quantifying
the effects of risk factors that were considered to be stable
(invariant) through the course of pregnancy from 24 weeks
gestation onwards. The fetuses-at-risk approach was pre-
ferred for this analysis as risk factors such as older maternal
age and chronic hypertension affect fetal growth and birth
rates and consequently RDS risk. Gestational age was
treated as survival time and took into account the fetal-
infant time continuum [19]. Maternal and infant charac-
teristics of interest included maternal age (<20, 20–34,
and ≥35 years), pre-existing or gestational diabetes melli-
tus, chronic hypertension, multi-fetal gestation, smoking
status, congenital anomalies and infant sex. Logistic
regression was used to obtain unadjusted and adjusted
odds ratios (OR) and 95 % confidence intervals (CI)
for each risk factor associated with RDS at early and
late gestation for this fetuses-at-risk analysis of
invariant risk factors.
Other potential factors with a variable time of onset in
early or late pregnancy (e.g., preeclampsia, placental
abruption) were not included in the fetuses-at-risk
analysis as our data source did not contain information
on their gestational age of onset (thus precluding a time
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varying assessment of effects). The relationship between
pregnancy complications and obstetric interventions and
early versus late gestation RDS was studied among live
births. Pregnancy complications included placental abrup-
tion, placenta previa, and hypertension in pregnancy,
eclampsia, and premature rupture of membranes. Obstet-
ric interventions included labour induction and cesarean
delivery. We also examined the morbidity correlates of
early vs late gestation RDS among live births by examining
the association between RDS and other neonatal morbidity
including 5-min Apgar scores (<4, 4–7 and ≥7), small-for-
gestational age live birth, neonatal seizures, assisted ventila-
tion <30 min, assisted ventilation ≥30 min, birth asphyxia
and meconium aspiration syndrome. Infants born small-
for-gestational age were identified based on birth weight-
for-gestational age being less than the 10th percentile of the
sex-specific United States national reference for fetal
growth [20]. Birth asphyxia [21] was defined as a 5-min
Apgar score <4, neonatal seizures and receipt of any
assisted ventilation. Associations between early (and late)
gestation RDS and pregnancy complications, obstetric
interventions and other neonatal morbidity, were quanti-
fied using ORs and 95 % CIs calculated among live births
in each gestational age category. No adjustment was
attempted for this descriptive analysis.
Sensitivity analyses examined associations between risk
factors, pregnancy complications, obstetric interventions
and co-morbidity and RDS occurring at 32–36 weeks
and 37–38 weeks. Sensitivity analyses also assessed
whether results changed upon adding fetal deaths to the
fetuses-at-risk analyses. All analyses were carried out
using SAS version 9.3. This study used publicly available
data and did not include patient identifiers; ethical
review was therefore not sought.
Results
Between 2005 and 2006, a total of 4,368,265 live births
contained information on RDS status and the risk
factors of interest, and were included in the study. Of
these, 27,971 received a diagnosis of RDS, yielding a
RDS rate of 6.4 per 1000 live births. Most of the RDS
cases occurred at 32–36 weeks gestation (42.7 %); 26.6 %
occurred at <32 weeks, 15.3 % occurred at 37–38 weeks
and 15.3 % occurred at ≥39 weeks. The cumulative inci-
dence of RDS by gestational week (which approximates
the incidence density of RDS) displayed a bimodal inci-
dence pattern by gestational age, peaking at late preterm
gestational, then declining slightly at 37 weeks only to
rise again at 39 weeks and beyond (Fig. 1).
Maternal and infant risk factors for early versus late
gestation RDS
The cumulative incidence rate of early gestation RDS (be-
tween 24 and 31 weeks, denominator of live births and
ongoing pregnancies at 24 weeks) was 1.7 per 1000 fetuses
at risk, while the cumulative incidence rate of late gestation
RDS (between 39 and 43 weeks, denominator of live births
and ongoing pregnancies at 39 weeks) was 1.6 per 1000
fetuses at risk. In unadjusted analyses, maternal age
<20 years and ≥35 years, multi-fetal gestation, smoking,
diabetes, chronic hypertension, small-for-gestational age,
congenital anomalies and infant sex were all significantly
associated with both early and late gestation RDS (Table 1).
Older maternal age (≥35 years) was significantly associated
with early gestation RDS but protective for late gestation
RDS.
Adjusted analyses showed that several factors differed
in their strength of association with early versus late
gestation RDS (Table 2). Diabetes mellitus was weakly
Fig. 1 Gestational age-specific incidence pattern of respiratory distress syndrome (RDS) expressed per 1000 fetuses at risk, United States 2005–06
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associated with RDS < 32 weeks (OR 1.31, 95 % CI 1.18–
1.44) and more strongly associated with RDS ≥39 weeks
(OR 1.74, 95 % CI 1.51–2.00; P value for heterogeneity
of odds ratios <0.05). Similarly, male sex was less
strongly associated with RDS <32 weeks (OR 1.09, 95 %
CI 1.04–1.14) as compared with RDS ≥39 weeks (OR
1.45, 95 % CI 1.36–1.54; P value for difference in odds
ratios <0.05). On the other hand, associations between
maternal age <20 years, multi-fetal pregnancy, chronic
hypertension, and congenital anomalies were stronger
with early gestation RDS than with late gestation RDS
(Table 2). For instance, chronic hypertension was
strongly associated with early gestation RDS (OR 3.89,
95 % CI 3.49–4.35) and moderately associated with late
gestation RDS (OR 1.65, 95 % CI 1.25–2.20).
Pregnancy complications and early versus late gestation
RDS
The rate of RDS among live births <32 weeks gestation
was 113.2 per 1000 live births, whereas the rate among
those born at ≥39 weeks was 1.6 per 1000 live births.
Rates of early gestation RDS were significantly higher
among live births with pregnancy complications such as
placental abruption, placenta previa, hypertension in
pregnancy, eclampsia and premature rupture of mem-
branes (Table 3). Rates of late gestation RDS were also
significantly higher among women with pregnancy
complications compared with women without pregnancy
complications. However, the associations between
pregnancy complications and early versus late gestation
RDS were markedly different and substantially stronger
between pregnancy complications and late gestation
RDS. For instance, placental abruption was moderately
associated with early gestation RDS (OR 1.76, 95 % CI
1.63–1.90) and strongly associated with late gestation
RDS (OR 6.33, 95 % CI 4.90–8.18; P value for difference
in odds ratios <0.05). Similarly, placenta previa, hyper-
tension in pregnancy, eclampsia and premature rupture
of membranes were weakly associated with early
gestation RDS and strongly associated with late gestation
RDS (Table 3).
Table 1 Rates of respiratory distress syndrome (RDS) per 1000 fetuses at risk at early (<32 weeks) and late (≥39 weeks) gestation
and unadjusted odds ratios and 95 % confidence intervals (CI) expressing the association between maternal and infant
characteristics and RDS, United States, 2005–2006
Risk factors RDS <32 weeks RDS ≥39 weeks
Cases Fetuses at risk Rate/1000a Odds ratiosb [95 % CI] Casess Fetuses at risk Rate/1000a Odds ratiosb [95 % CI]
Age <20 years 959 434,604 2.2 1.38 [1.29, 1.48] 545 272,042 2.0 1.25 [1.14, 1.37]
20–34 5314 3,312,305 1.6 Reference 3249 2,024,271 1.6 Reference
≥35 1177 621,356 1.9 1.06 [1.04, 1.08] 493 354,606 1.4 0.95 [0.92, 0.98]
Multi-fetal gestation 2169 150,761 14.4 11.6 [11.1, 12.2] 41 7103 5.8 3.61 [2.65, 4.91]
Smoking 1081 450,149 2.4 1.48 [1.39, 1.58] 582 253,288 2.3 1.49 [1.36, 1.62]
Diabetes 445 163,802 2.7 1.63 [1.48, 1.80] 207 74,377 2.8 1.76 [1.53, 2.02]
Chronic hypertension 355 47,353 7.5 4.60 [4.13, 5.12] 49 17,144 2.9 1.78 [1.34, 2.36]
Congenital anomaly 1000 64,417 15.5 10.5 [9.83, 11.2] 358 31,777 11.3 7.59 [6.81, 8.46]
Male sex 4004 2,235,753 1.8 1.11 [1.06, 1.16] 2581 1,340,148 1.9 1.48 [1.39, 1.57]
All 7450 4,368,265 1.7 - 4287 2,650,919 1.6 -
aRates of RDS <32 weeks represent cumulative incidence from 24 to 31 weeks (8 week period) and cannot be directly compared with rates of RDS ≥39 weeks
which represent cumulative incidence from 39 to 43 weeks (5 week period)
bOdds ratios were estimated by contrasting the RDS rate among those with and those without the risk factor e.g., RDS < 32 weeks among infants of smokers vs
nonsmokers. Since odds ratios express the relative effect of risk factors on RDS, the odds ratios for early gestation RDS can be directly compared with the odds
ratios for late gestation RDS
Table 2 Adjusted odds ratios and 95 % confidence intervals (CI)
expressing the association between maternal and infant
characteristics and early (<32 weeks) and late (≥39 weeks)
gestation respiratory distress syndrome (RDS), United States,
2005–2006
Adjusted odds ratios [95 % CI]
RDS <32 weeks RDS ≥39 weeks
Maternal age <20 years 1.59 [1.48, 1.71] 1.25 [1.14, 1.37]
20–34 Reference Reference
≥35 0.99 [0.97, 1.01] 0.95 [0.92, 0.98]
Multifetal gestation 11.6 [11.0, 12.2] 3.66 [2.68, 4.98]
Smoking 1.53 [1.43, 1.63] 1.44 [1.32, 1.57]
Diabetes 1.31 [1.18, 1.44] 1.74 [1.51, 2.00]
Chronic hypertension 3.89 [3.49, 4.35] 1.65 [1.25, 2.20]
Any congenital anomaly 9.41 [8.79, 10.1] 7.25 [6.50, 8.09]
Male sex 1.09 [1.04, 1.14] 1.45 [1.36, 1.54]
Odds ratios were estimated by contrasting the outcome among those with
and those without the risk factor e.g., RDS < 32 weeks among infants of
smokers vs non-smokers
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Obstetric interventions and early and late gestation RDS
Table 3 also shows the association between labour
induction and cesarean delivery and early versus late
gestation RDS. Labour induction had a significant pro-
tective effect on early gestation RDS and was a signifi-
cant but weak risk factor for late gestation RDS.
Cesarean delivery was significantly associated with both
early and late gestation RDS but the effect was substan-
tially larger at late gestation (OR 1.28 vs OR 2.27;
P value for difference in odds ratios <0.05). Restricting
the analysis to women without pregnancy complications
(i.e., without maternal hypertension, eclampsia, diabetes
mellitus, placental abruption/previa and congenital
anomaly) did not drastically alter the results, although
the association between labour induction with early
gestation RDS became non-significant.
Morbidity correlates of early and late gestation RDS
The association between neonatal co-morbidity and early
gestation RDS was very different from the association
between neonatal co-morbidity and late gestation RDS
(Table 4). Apgar score < 4 at 5 min, small-for-gestational
age live birth, and meconium aspiration syndrome were not
associated with early gestation RDS, while neonatal
seizures, ventilation, and birth asphyxia were strongly
associated with early gestational RDS. On the other hand,
small-for-gestational age live birth was significantly and
moderately associated with late gestation RDS, while the
Table 3 Rates respiratory distress syndrome (RDS) at early (<32 weeks) and late (≥39 weeks) gestation per 1000 live births and
unadjusted odds ratios and 95 % confidence intervals (CI) expressing the association between pregnancy complications and
obstetric interventions, and RDS, United States, 2005–2006
RDS <32 weeks RDS ≥39 weeks
No. Rate per 1000 Odds ratio [95 % CI] No. Rate per 1000 Odds ratio [95 % CI]
Pregnancy complications
Placental abruption 836 176 1.76 [1.63, 1.90] 60 10 6.33 [4.90, 8.18]
Placenta previa 199 153.2 1.43 [1.23, 1.67] 25 7.2 4.51 [3.04, 6.69]
Hypertension in pregnancy 1007 154.3 1.50 [1.39, 1.61] 230 3.6 2.31 [2.02, 2.63]
Eclampsia 287 174 1.68 [1.47, 1.91] 27 6.9 4.33 [2.96, 6.33]
Premature rupture of membranes 1510 141.9 1.37 [1.29, 1.46] 107 4.2 2.65 [2.19, 3.21]
Interventions
Labour induction 280 90.9 0.78 [0.68, 0.88] 1225 1.8 1.17 [1.09, 1.25]
Cesarean delivery 5146 121.9 1.28 [1.22, 1.35] 1881 2.8 2.27 [2.13, 2.41]
Labour inductiona 115 65.8 0.70 [0.58, 0.85] 947 1.6 1.18 [1.09, 1.27]
Cesarean deliverya 2503 94.0 1.12 [1.05, 1.19] 1429 2.3 2.16 [2.02, 2.31]
All live births 7450 113.2 - 4287 1.6 -
aExcluding live births with maternal hypertension, eclampsia, diabetes mellitus, placental abruption, placenta previa and any congenital anomaly
Table 4 Rates respiratory distress syndrome (RDS) at early (<32 weeks) and late (≥39 weeks) gestation per 1000 live births and
unadjusted odds ratios and 95 % confidence intervals (CI) expressing the association between neonatal co-morbidity and RDS,
United States, 2005–2006
RDS <32 weeks RDS ≥39 weeks
No. Rate per 1000 Odds ratio [95 % CI] No. Rate per 1000 Odds ratio [95 % CI]
Apgar at 5 min <4 404 111.5 1.03 [0.92, 1.14] 108 45 33.1 [27.2, 40.2]
4–6 1272 142.1 1.36 [1.27, 1.45] 421 34.1 24.8 [22.4, 27.5]
≥7 5688 108.8 Reference 3741 1.4 Reference
Small for gestational age 786 113 1.00 [0.92, 1.08] 562 2.6 1.73 [1.58, 1.89]
Neonatal seizures 30 428.6 5.90 [3.67, 9.47] 30 22.6 14.4 [10.0, 20.7]
Ventilation≥ 30 min 4416 320.9 7.64 [7.26, 8.04] 695 93.6 75.9 [69.7, 82.6]
Ventilation <30 min 503 145.4 1.36 [1.23, 1.50] 351 9.5 6.36 [5.70, 7.10]
Birth asphyxia 4983 255.5 6.20 [5.88, 6.53] 1106 23.5 19.7 [18.4, 21.2]
Meconium aspiration syndrome 10 192.3 1.87 [0.94, 3.72] 228 57.6 39.8 [34.7, 45.6]
All live births 7450 113.2 - 4287 1.6 -
Birth asphyxia was defined as Apgar at 5 min <4, presence of neonatal seizures, or any assisted ventilation. Births with missing Apgar values excluded from
the analysis
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other types of neonatal morbidity were all very strongly
associated with late gestation RDS. These differences in
morbidity correlates between early and late gestation RDs
were particularly evident with regard to 5-min Apgar <4, 5-
min Apgar 4–6, neonatal seizures, ventilation ≥30 min,
birth asphyxia and meconium aspiration syndrome. For
example, meconium aspiration syndrome was non-
significantly associated with early gestation RDS (OR 1.87,
95 % CI 0.94–3.72) but very strongly associated with late
gestation RDS (OR 39.8, 95 % CI 34.7–45.6).
Sensitivity analyses
The strength of the association between the factors studied
and RDS at 32–36 and 37–38 weeks was generally in
between that observed with early gestation RDS (<32 weeks)
and late gestation RDS (≥39 weeks) with some exceptions.
Diabetes mellitus was more strongly associated with RDS at
37–38 weeks (OR 2.74, 95 % CI 2.74–3.03) compared with
RDS at other gestational ages. Similarly, the association
between congenital anomalies and RDS at 32–36 weeks
gestation (OR 4.47, 95 % CI 4.41–5.09) was stronger than
that observed with RDS in other gestational age categories.
Associations between placenta previa, eclampsia, premature
rupture of membranes and RDS at 37–38 weeks were simi-
lar in magnitude to associations between the same compli-
cations and RDS at 32–36 weeks, while associations
between neonatal co-morbidity and RDS at 37–38 weeks
were more similar to associations between neonatal co-
morbidity and RDS at ≥39 weeks (Appendix Tables 5–8).
Sensitivity analyses including stillbirths in the denominator
made no marked change in the results or interpretation
(Appendix Tables 9–10).
Discussion
Our study showed that RDS occurring at late term
gestation (≥39 weeks) constituted an important frac-
tion (15.3 %) of RDS. Early and late gestation RDS
differed in terms of potential etiologic factors; mater-
nal and infant characteristics such as maternal age
<20 years, multi-fetal gestation, chronic hypertension,
and congenital anomalies were more strongly associ-
ated with early gestation RDS, while factors such as
pre-existing diabetes, gestational diabetes and male
infant sex were more strongly associated with late
gestation RDS. Associations between pregnancy
complications, obstetric intervention and neonatal
morbidity and early RDS also differed from associa-
tions with late gestation RDS. Of particular interest
were the differential and very strong associations
between late gestation RDS and pregnancy complica-
tions (such as placental abruption, placenta previa and
eclampsia) and neonatal co-morbidity (especially
Apgar <4 at 5 min, neonatal seizures, ventilation
≥30 min, birth asphyxia and meconium aspiration
syndrome). These differences suggest substantial
heterogeneity in the etiology, pathologic features and
clinical presentation of early and late gestation RDS.
Our findings confirm previous reports that RDS at term
is associated with [8–12, 14] meconium aspiration
syndrome, diabetes, cesarean delivery, birth asphyxia and
congenital anomalies [8–12, 14]. In addition, we identified
several other risk factors for RDS ≥39 weeks including
multi-fetal gestation, chronic hypertension and male infant
sex. The strong associations between late gestation RDS
and Apgar <4 at 5 min, neonatal seizures, ventilation
≥30 min and birth asphyxia appears to be more consistent
with a clinical picture of encephalopathy as opposed to
surfactant deficiency or other pulmonary causes. The
differential and much stronger associations between preg-
nancy complications such as placental abruption, placenta
previa, and eclampsia and late RDS, suggest that the fetal
central nervous system is increasingly susceptible to serious
compromise at later gestation. The stronger associations
between male sex and small-for-gestational age and late
gestation RDS may also indicate a greater susceptibility to
encephalopathy [22, 23]. There is a substantial body of
animal and human literature showing that the fetal gas
exchange and oxygenation is significantly reduced at term
gestation and beyond [24–27]. Although uterine artery
blood flow increases with gestation, blood flow per unit of
fetal weight does not, and arterial partial pressure of
oxygen, base excess, oxygen saturation, oxygen content,
and arterial partial pressure of carbon dioxide are all
reduced at late gestation. The increase in rates of placental
complications at late gestation is also congruent with epide-
miologic models of stillbirth and perinatal death (which
also increase at late gestation) [3].
It is unclear why we observed a negative association
between induction and RDS at <32 weeks gestation. One
possible explanation is that infants induced at <32 weeks
(as opposed to those that delivered spontaneously at this
age) were more likely to have received antenatal corticoster-
oid therapy, which is protective for RDS [28]. The associ-
ation between cesarean delivery and RDS at ≥39 weeks
gestation is consistent with findings from previous studies
[10–13] which have proposed mechanisms such as lung
immaturity [13], the lack of hormonal processes that
initiate and propagate labour and which may be involved in
lung function, and the effects of labour and vaginal delivery
in clearing lung fluid [29].
The limitations of our study include the absence of infor-
mation on maternal infection and severity of respiratory
distress syndrome. In addition, the information in our data
source was obtained through routine abstraction and hence
may have been subject to some coding variation and tran-
scription errors. However, these problems are likely to have
been non-differential by gestational age and RDS status and
hence would have had a limited impact on our findings.
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Conclusions
Our study shows that a significant fraction of RDS
occurs at late term gestation. Risk factors such as
maternal age, pre-existing and gestational diabetes
mellitus, multi-fetal gestation, chronic hypertension
and infant sex are differently associated with early and
late gestation RDS. Also, the associations between preg-
nancy complications, and neonatal co-morbidity (that
are components of neonatal encephalopathy) are much
stronger with late gestation RDS as compared with
early gestation RDS. The clinico-epidemiologic picture
associated with early and late gestation RDS suggests
that these two conditions are distinct disease entities.
Further research elucidating the pathogenesis of late
gestation RDS will help to clarify the management
options for better treating this condition.
Table 5 Rates of respiratory distress syndrome (RDS) at 32–36 weeks and 37–38 weeks per 1000 fetuses at risk and unadjusted odds
ratios and 95 % confidence intervals (CI) expressing the association between maternal and infant characteristics and RDS, United
States, 2005–2006
Risk factors RDS 32–36 weeks RDS 37–38 weeks
Cases Fetuses at risk Rate/1000a Odds ratiosb [95 % CI] Cases Fetuses at risk Rate/1000a Odds ratiosb [95 % CI]
Age <20 years 1165 426,327 2.7 1.00 [0.94, 1.06] 360 386,323 0.93 0.83 [0.74, 0.92]
20–34 8969 3,265,775 2.7 Reference 3364 2,978,793 1.13 Reference
≥35 1808 610,342 3.0 1.03 [1.01, 1.04] 568 545,748 1.04 0.97 [0.95, 1.00]
Multi-fetal gestation 2770 133,526 20.7 9.61 [9.21, 10.0] 214 55,869 3.83 3.63 [3.16, 4.17]
Smoking 1613 441,604 3.7 1.37 [1.30, 1.44] 632 392,595 1.61 1.55 [1.42, 1.69]
Diabetes mellitus 996 160,801 6.2 2.35 [2.20, 2.51] 414 136,882 3.02 2.95 [2.67, 3.27]
Chronic hypertension 423 44,759 9.5 3.52 [3.19, 3.88] 126 35,036 3.60 3.35 [2.81, 4.01]
Congenital anomaly 832 61,034 13.6 5.26 [4.90, 5.65] 346 50,707 6.82 6.71 [6.01, 7.50]
Male sex 7130 2,200,877 3.2 1.42 [1.37, 1.47] 2739 1,994,128 1.37 1.70 [1.59, 1.81]
All 11,942 4,302,444 2.8 - 4292 3,910,864 1.10 -
aRates of RDS <32 weeks represent cumulative incidence from 24 to 31 weeks (8 week period) and cannot be directly compared with rates of RDS ≥39 weeks
which represent cumulative incidence from 39 to 43 weeks (5 week period)
bOdds ratios were estimated by contrasting the RDS rate among those with and those without the risk factor e.g., RDS < 32 weeks among infants of smokers vs
nonsmokers. Since odds ratios express the relative effect of risk factors on RDS, the odds ratios for early gestation RDS can be directly compared with the odds
ratios for late gestation RDS
Table 6 Adjusted odds ratios and 95 % confidence intervals (CI) expressing the association between maternal and infant
characteristics and respiratory distress syndrome (RDS) at 32–36 weeks and 37–38 weeks, United States, 2005–2006
Adjusted odds ratios [95 % CI]
RDS 32–36 weeks RDS 37–38 weeks
Maternal age <20 years 1.14 [1.07, 1.21] 0.86 [0.78, 0.96]
20–34 Reference Reference
≥35 0.97 [0.95, 0.98] 0.95 [0.92, 0.97]
Multi-fetal gestation 9.6 [9.2, 10.0] 3.65 [3.18, 4.20]
Smoking 1.42 [1.35, 1.50] 1.55 [1.42, 1.68]
Diabetes mellitus 2.04 [1.90, 2.18] 2.71 [2.45, 3.01]
Chronic hypertension 2.86 [2.59, 3.16] 2.74 [2.29, 3.28]
Any congenital anomaly 4.81 [4.48, 5.17] 6.22 [5.57, 6.94]
Male sex 1.41 [1.36, 1.46] 1.67 [1.57, 1.77]
Odds ratios were estimated by contrasting the outcome among those with and those without the risk factor e.g., RDS 37–38 weeks among infants/fetuses at risk
of smokers vs. non-smokers
Appendix
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Table 9 Sensitivity analysis including stillbirths: Crude odds ratios and 95 % confidence intervals (CI) expressing the association
between early antepartum characteristics and respiratory distress syndrome (RDS), United States, 2005–2006
Unadjusted odds ratios [95 % CI]
RDS < 32 weeks RDS 32–36 weeks RDS 37–38 weeks RDS ≥39 weeks
Maternal age <20 years 1.38 [1.29, 1.48] 1.00 [0.94, 1.06] 0.83 [0.74, 0.92] 1.25 [1.14, 1.37]
20–34 Reference Reference Reference Reference
≥35 1.06 [1.04, 1.08] 1.03 [1.01, 1.04] 0.97 [0.95, 1.00] 0.95 [0.92, 0.98]
Multifetal gestation 11.6 [11.1, 12.2] 9.60 [9.20, 10.0] 3.63 [3.16, 4.17] 3.60 [2.65, 4.91]
Smoking 1.48 [1.38, 1.58] 1.37 [1.30, 1.44] 1.55 [1.42, 1.68] 1.49 [1.36, 1.62]
Diabetes 1.63 [1.48, 1.79] 2.35 [2.20, 2.51] 2.95 [2.66, 3.26] 1.76 [1.53, 2.02]
Chronic hypertension 4.57 [4.10, 5.08] 3.51 [3.18, 3.87] 3.35 [2.81, 4.00] 1.78 [1.34, 2.36]
Any congenital anomaly 10.3 [9.61, 11.0] 5.20 [4.84, 5.58] 6.67 [5.97, 7.45] 7.55 [6.78, 8.42]
Male sex 1.11 [1.06, 1.16] 1.42 [1.37, 1.47] 1.70 [1.59, 1.81] 1.48 [1.39, 1.57]
Table 7 Rates respiratory distress syndrome (RDS) at 32–36 weeks and 37–38 weeks per 1000 live births and unadjusted odds ratios and
95 % confidence intervals (CI) expressing the association between pregnancy complications and obstetric interventions, and RDS at 32–36
weeks and 37–38 weeks, United States, 2005–2006
RDS 32–36 weeks RDS 37–38 weeks
No. Rate per 1000 Odds ratio [95 % CI] No. Rate per 1000 Odds ratio [95 % CI]
Pregnancy complications
Placental abruption 645 78.0 2.79 [2.57, 3.03] 102 17.9 5.43 [4.45, 6.62]
Placenta previa 348 63.8 2.20 [1.97, 2.46] 44 9.0 2.67 [1.98, 3.59]
Hypertension in pregnancy 1748 44.1 1.55 [1.47, 1.63] 449 6.8 2.12 [1.92, 2.34]
Eclampsia 321 58.0 1.98 [1.77, 2.22] 43 8.9 2.66 [1.97, 3.59]
Premature rupture of membranes 1430 46.3 1.62 [1.53, 1.71] 104 6.3 1.88 [1.55, 2.29]
Interventions
Labour induction 1455 26.6 0.85 [0.81, 0.90] 953 3.6 1.08 [1.00, 1.16]
Labour inductiona 697 20.7 0.80 [0.74, 0.87] 586 2.9 1.07 [0.98, 1.17]
Cesarean delivery 6971 40.7 1.84 [1.77, 1.91] 2340 5.7 2.48 [2.34, 2.64]
Cesarean deliverya 3826 32.8 1.64 [1.57, 1.72] 1512 4.5 2.32 [2.16, 2.49]
All live births 11,942 30.5 - 4292 3.4 -
Odds ratios were estimated by contrasting outcomes among those with and those without the risk factor e.g., RDS at 37–38 weeks among infants of women
delivering with placental abruption vs. infants of women without placental abruption
aExcluding live births with maternal hypertension, eclampsia, diabetes mellitus, placental abruption, placenta previa and any congenital anomaly
Table 8 Rates respiratory distress syndrome (RDS) at 32–36 weeks and 37–38 weeks per 1000 live births among infants with other
neonatal morbidity, and unadjusted odds ratios and 95 % confidence intervals (CI) expressing the association between neonatal
comorbidity and RDS at 32–36 weeks and 37–38 weeks, United States, 2005–2006
RDS 32–36 weeks RDS 37–38 weeks
No. Rate per 1000 Odds ratio [95 % CI] No. Rate per 1000 Odds ratio [95 % CI]
Apgar at 5 minutes <4 165 85.2 3.13 [2.67, 3.68] 50 34.5 11.4 [8.6, 15.1]
4–6 733 99.9 3.73 [3.45, 4.04] 309 45.1 15.0 [13.3, 16.9]
≥7 11,009 28.9 Reference 3917 3.1 Reference
Small for gestational age 2202 32.7 1.09 [1.04, 1.14] 645 4.8 1.48 [1.36, 1.61]
Neonatal seizures 27 102.3 3.63 [2.44, 5.40] 12 20.1 6.04 [3.41, 10.70]
Ventilation ≥ 30 min 3428 236.1 13.4 [12.8, 14.0] 858 144.4 61.5 [56.8, 66.6]
Ventilation <30 min 766 64.9 2.29 [2.12, 2.47] 294 16.3 5.14 [4.56, 5.79]
Birth asphyxia 4244 153.1 8.37 [8.05, 8.71] 1175 46.3 19.2 [18.0, 20.6]
Meconium aspiration syndrome 38 140.7 5.22 [3.70, 7.36] 66 72.8 23.3 [18.1, 30.0]
All live births 11,942 30.5 - 4292 3.4 -
Birth asphyxia was defined as Apgar at 5 minute <4, presence of neonatal seizures, or any assisted ventilation. Births with missing Apgar values excluded from the
analysis. Odds ratios were estimated by contrasting outcomes among those with and those without the risk factor e.g., RDS at 37–38 weeks among infants with
and without meconium aspiration syndrome
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